JGM into a class of 10-12 nm calcium-binding microfibrils [4] that are abundantly expressed not only in elastic tissues, such as the aorta, lung and skin, but also in non-elastic tissues, such as the ciliary zonules of the eye [5] . A mutation in the FBN1 gene causes an interruption in microfibril formation, thereby resulting in attenuated connective tissue structure. Therefore, patients with MFS have a pleiotropic phenotype involving mainly the skeletal, ophthalmologic and cardiovascular systems [1, 5] .
Introduction
Marfan syndrome (MFS; OMIM#154700) is a systemic inherited disorder of the connective tissue with an autosomal dominant mode of transmission caused by a mutation in the fibrillin-1 gene (FBN1, OMIM#134797) in more than 90% of patients [1, 2] . FBN1, located on chromosome 15q-21.1, is a 230 kb gene containing 65 exons, encoding the extracellular matrix protein FBN1 [2, 3] . MFS is a relatively common syndrome with an estimated prevalence of 1 in 10,000-20,000 individuals [3] , without a gender or ethnic predisposition [2] . FBN1 is assembled been identified [6] . Here we report the case of a novel mutation in the FBN1 gene in a MFS patient with relatively typical MFS features who underwent a pneumothorax at an earlier age than that of previously reported patients without a family history or cardiovascular manifestations.
Case
A 10-year-old girl visited Soonchunhyang University Bucheon Hospital (Bucheon, Korea) for precocious puberty evaluation. According to her medical history, she underwent a pulmonary wedge resection to correct a spontaneous pneumothorax at the age of 9 years (Fig. 1) . There was no family history of MFS. Her father's and mother's height were 171 cm and 165 cm, respectively, giving a mid-parental height of 161.5 cm. At that time of presentation, her height was 162 cm (>97th percentile), and her weight was 40 kg (75th-90th percentile), with an upper/lower segment ratio of 1.06. Her bone age was approximately 11 years (Fig. 2) . On the ophthalmologic examination, there were no abnormal findings except for bilateral myopia. There was arachnodactyly but no wrist sign. At the age of 14 years, she presented at the hospital again with the chief complaint of scoliosis (Fig. 3) . On physical examination her height was 170 cm, and weight was 50 kg (Fig. 4 ). She presented with arachnodactyly and wrist sign (Fig. 5) . Skin striae were evident on her back. She also had pectus excavatum and pes planus. According to the systemic scoring system for the revised Ghent diagnostic criteria, a score ≥7 indicates systemic involvement; the patient had a score of 8 including a history of a pneumothorax. We had an echocardiograph with the suspicion of MFS, but there was no evidence of cardiac abnormalities such as mitral valve prolapse. The size of the ascending aorta, arch and descending aorta were normal.
To determine the genetic background of our patient, the primary candidate gene FBN1 was amplified by polymerase chain reaction, and the products were directly sequenced. Informed consent was obtained from the subject. Deletion of a cytosine residue in exon 7 (c.660delC) was identified (Fig. 6 ). This is a novel mutation causing a frameshift of protein synthesis and is predicted to create a premature stop codon. As she suffered from limited motion and back pain due to scoliosis, she underwent an operation for posterior reduction and posterior fixation instrumentation on T5-L4.
Although the patient's parents did not display MFS features, we recommended that her family undergo a thorough clinical examination, including slip lamp examination and echocardiogram, and additional DNA sequencing for MFS. They refused this recommendation due to the expense.
Discussion
MFS is an autosomal dominant disorder of the connective tissue, caused mainly by a mutation in the FBN1 gene. In addition to MFS, other conditions including isolated ectopia lentis, autosomal dominant Weill-Marchesani syndrome, MASS (mitral valve prolapse, aortic enlargement, skin and skeletal findings) syndrome, and Shprintzen-Goldberg craniosynostosis syndrome are associated with this gene [4] . FBN1 gene mutations are expected to act in a dominant negative manner, thereby explaining the variety of clinical phenotypes of MFS [7] .
Diagnosis of MFS and other related conditions is based on clinical features. However, because of the wide phenotypic spectrum, the clinical diagnosis may be questionable even after improvement of diagnostic investigations [8] .
In 2010 the revised Ghent criteria (Ghent criteria 2) were suggested for the identification of patients at risk for cardiovascular manifestations, as they provide simple-touse diagnostic criteria, allow for an early diagnosis, take into consideration the availability and costs of the diagnostic tests, and improve the definition of differential diagnosis [9] . According to Ghent criteria 2, "If an FBN1 mutation is identified in sporadic or familial cases but aortic root measurements are still below Z=3, we propose to use the term 'potential MFS' until the aorta reaches threshold." [10] . As our patient had a novel FBN1 mutation without cardiovascular involvement, our diagnosis was 'potential MFS' .
Likewise, the age-related nature of some clinical manifestations and pleiotropic expression may affect the exact diagnosis, particularly in children. Faivre et al. [11] reported that only 56% of children, versus 79% of adults, would have been diagnosed on clinical phenotype alone, implying that the rate of meeting the international criteria increases with age. In this context, some experts have questioned the Ghent criteria, which are unreliable in infancy and childhood, when the phenotype has not manifested fully. It is important to identify children at risk of MFS as soon as possible to allow for appropriate treatment and to avoid misdiagnosis. Most patients experience significant physical limitations, a diminished level of self-confidence, social and interpersonal difficulties, emotional stress and limited job opportunities [12] . Because of these issues, it is necessary to diagnose MFS accurately, and special considerations are needed for children. Therefore, we have recommended a safe followup regimen involving echocardiogram and ophthalmologic examinations for reevaluating the upcoming manifestations of MFS until an accurate diagnosis is verified [11] .
It has been reported that the frequency of spontaneous pneumothorax was 4.4% in MFS patients older than 12 years [13] , which is higher than in general population. Although our patient was not diagnosed with typical MFS according to the Ghent criteria 2, she may be predisposed to suffer from pneumothorax due to abnormal connective tissue constituents in the lung parenchyma. According to another study, pneumothorax was found in patients aged 17-36 years (mean age of 21 years) [14] . However, the case reported here had a spontaneous pneumothorax at 9 years of age, which is younger than that reported previously in MFS patients.
Cardiovascular abnormalities of MFS include aortic valve insufficiency, aortic dilation, tear and rupture, mitral valve prolapse with or without regurgitation, and enlargement of the proximal pulmonary artery [10] . Lipscomb et al. [15] focused on the physical characteristics of affected individuals, and echocardiographic findings of mild aortic root dilatation became apparent at 9-15 years of age. Our patient did not show any cardiovascular complications in the multiple evaluations performed at 15 years of age. However, we should not exclude a diagnosis of MFS who absence of cardiac involvement until adulthood. This is why we have performed annual echocardiographic follow-ups throughout childhood on the patient to detect early aortic root dilatation and other cardiac involvement, to identify whether the novel FBN1 mutation is associated with cardiovascular manifestation.
In our study, the identified frameshift mutation c.660delC in exon 7 of the FBN1 gene has not been reported in the literature. Interestingly, mutations most likely occur in exons 2, 15, 22, 27, 46, 55, and 62 and much less frequently in exons 7, 41, and 65 [3] . According to the Universal Mutation Database-FBN1, only eight different mutations in exon 7 have been reported [16] . This case adds a novel mutation to the existing spectrum of FBN1 mutations and places emphasis on the need for a genetic diagnosis.
On physical examination, skin striae, pectus excavatum, pes planus, arachnodactyly, wrist sign, scoliosis and bilateral myopia were revealed without cardiovascular system abnormalities. Because of the quantitative mRNA expression of the mutant allele [17] , it is difficult to know the effect of novel mutation and what will be the phenotype. There have been many attempts to clarify the relationship between the genotype and phenotype in Korean patients with MFS. Oh et al. [18] reported six novel mutations in the FBN1 gene in Korean patients and Yoo et al. [19] identified 27 novel mutations in Korean patients to verify the clinical phenotypes and mutation spectrum of the FBN1gene; however, no clear correlations have been found. Therefore, further analysis is needed to identify the role of FBN1 mutations.
In conclusion, we identified a single missense mutation in the FBN1 gene (c.660delC) in a potential MFS patient. She had a history of a pneumothorax at 9 years of age, which is an earlier age than in other reports, but no cardiac abnormalities in her teenage years. With accurate knowledge of the specific roles of the different underlying FBN1 mutations, we can gain benefits regarding prognosis and swift patient management at an early stage.
